You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. DGPS-Based Trilateration Positioning Receiver

    SBC: Swaszek Peter            Topic: 07FH1

    Positioning and navigation have become a mainstay of everyday life in the U.S.; applications of interest include navigation of vehicles of all kinds, infrastructure mapping, and safety of life systems. Many of these recent applications have become possible through the GPS. With the recognized vulnerabilities of GPS, it is evident that equivalent backup systems must be developed. One possible so ...

    SBIR Phase I 2008 Department of Transportation
  2. Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing

    SBC: BCR DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacillus spores. Fluorogenic spores (F-spores) produced at BCR appear to be phy siologically identical to normal spores except for performing as self reporters of initial germination events. Considering the unique features ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  3. T1D Tolerance Induction with Natural Treg Epitopes

    SBC: EPIVAX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Type 1 (juvenile) diabetes is an organ-specific autoimmune disease resulting from destruction of insulinproducing pancreatic beta-cells. In non-diabetics, islet cell antigen-specific T cells are either deleted in thymic development or are converted to T regulatory cells that actively suppress effector responses to islet cell antigens. In juvenile diabetics and ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  4. A New Modular Tool Set for Live Imaging and Manipulating the Nervous System

    SBC: Montana Molecular LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A New Modular Tool Set for Live Imaging and Manipulating the Nervous System Project summary. The nervous system contains the most complex and heterogeneous set of cell types in the body. Modern approaches in imaging, an d genetically encoded reporters based on the Green Fluorescent Protein (GFP), have made it possible to explore some of the dynamic processes in ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  5. High Content Drug Screening with Cardiac Tissue

    SBC: MYOMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Myomics, Inc. has developed High Content Drug Screening (HCS) technology for in vitro testing of compounds which alter contractile forces generated by miniaturized tissue engineered organs (Myo-Force Assay SystemTM, MFA STM). Myomics' 3-D tissue/force sensor composite is capable of long term studies (1-4 weeks) and provides force as well as electrophysiological ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. OCEAN WAVE ENERGY CONVERTER

    SBC: Ocean Wave Energy Co            Topic: N/A

    MAJOR AIDS TO NAVIGATION (ATON) ARE ESSENTIAL SIGNPOSTS FOR SAFE PASSAGE ALONG COASTAL AND OFFSHORE SEAWAYS. PRESENTLY, THEIR SIGNALS ARE POWERED BY ON-SITE ENGINE GENERATORS REQUIRING CONSIDERABLE AND COSTLY MAINTENANCE. ATON AUTONOMY WILL BE GREATLY INCREASED WITH DEEP DISCHARGE BATTERY TECHNOLOGY PROVIDING THAT ON-SITE CHARGING SOURCES ARE USED. AMONG NATURALLY AVAILABLE SOURCES, THE UNCEASING ...

    SBIR Phase I 1989 Department of Transportation
  7. Isoindolinones as Antimicrobial Agents

    SBC: Promiliad Biopharma Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): Antibiotic resistance among common pathogens is a serious public health problem because it compromises our ability to treat many infectious diseases. The problem has been compounded by the lack of discovery of new antib iotics that act in novel ways. Such compounds are critically needed as bacterial resistance to older antibiotics, and even their newer derivati ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Enhanced Dynamic Range Proteomic Analysis

    SBC: Resonon, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): A novel enhanced dynamic range camera (EDRaC) is proposed for greatly improved fluorescence detection in proteomics. In the longer term the EDRaC can improve the performance of a wide range of biomedical applications us ing fluorescent microwell plate reading and/or microscopy. The initial emphasis will be to develop, demonstrate, and apply the technology to mu ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Self-Management Technology for Asthmatic Teens (STAT)

    SBC: STATE OF THE ART, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Although most adverse outcomes due to asthma can be prevented through appropriate medical care and disease management, adolescents continue to be at high risk for negative consequences of uncontrolled asthma. Two contri buting factors are 1) Failure of adolescents to understand Asthma as a chronic illness requiring scheduled medication rather than episodic resp ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. HIV and Sober Intimate Behavior (HSIB)

    SBC: STATE OF THE ART, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Drug abuse-associated behavior continues to be a significant factor in the spread of HIV/AIDS in the United States - both directly and indirectly. The use of injection and non-injection illicit drugs, as well as alcoho l, can increase HIV transmission risk through its impact on decision making and sexual risk taking. To address this issue, State of the Art, In ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government